Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Feb 5;25(4):657–664. doi: 10.1158/1055-9965.EPI-15-0849

Table 3.

Hazard ratios (95% CI) of death from total cancer and cancer types by quartiles of serum B2M; ARIC, 1990–2011.

Cause of death No. of

deaths
Quartiles of B2M (mg/L)

≤1.66 1.67–1.88 1.89–2.15 ≥2.16 P-trend
Total cancer 1160 237 261 322 344
  Person-years 219,393 57,374 57,868 54,563 49,588
  Mortality ratea 5.29 4.13 4.51 5.90 6.94
  Model 2b 1 (reference) 0.92 (0.76–1.12) 1.09 (0.89–1.34) 1.30 (1.02–1.64) 0.01

Colorectal cancer 85 13 27 24 21
  Person-years 219,393 57,374 57,868 54,563 49,588
  Mortality rate 0.39 0.23 0.47 0.44 0.42
  Model 2 1 (reference) 1.60 (0.77–3.32) 1.50 (0.68–3.33) 1.73 (0.68–4.44) 0.34

Lung cancer 352 70 84 84 114
  Person-years 219,393 57,374 57,868 54,563 49,588
  Mortality rate 1.60 1.22 1.45 1.54 2.30
  Model 2 1 (reference) 1.05 (0.73–1.50) 1.05 (0.72–1.55) 1.69 (1.10–2.59) 0.02

Breast cancer (women only) 77 19 18 23 17
  Person-years 124,783 34,480 31,434 29,888 28,982
  Mortality rate 0.62 0.55 0.57 0.77 0.59
  Model 2 1 (reference) 1.12 (0.49–2.53) 1.23 (0.51–2.95) 0.80 (0.26–2.47) 0.83

Prostate cancer 58 14 15 20 9
  Person-years 94,609 22,894 26,434 24,676 20,605
  Mortality rate 0.61 0.61 0.57 0.81 0.44
  Model 2 1 (reference) 0.78 (0.36–1.68) 0.93 (0.42–1.68) 0.42 (0.14–2.07) 0.25

Hematological cancers 138 21 29 34 54
  Person-years 219,393 57,374 57,868 54,563 49,588
  Mortality rate 0.63 0.37 0.50 0.82 1.09
  Model 2 1 (reference) 1.21 (0.64–2.28) 1.48 (0.78–2.82) 2.44 (1.20–4.95) 0.001
a

Per 1,000 person-years

b

Multivariable model (Model 2, Table 2) – adjusted for age, sex, race, study center, education, BMI, smoking status and pack-years of smoking, use of aspirin, hormone replacement therapy (in women) and eGFR.